World Indices Forecast: ^VXO and ^VIX Brought High Returns To Investors

October 28, 2018

The Stock Market Is Down, Volatility Is Up As Forecasted

Created by the Chicago Board Options Exchange (CBOE), The Volatility Index, or VIX, is a measure of uncertainty in the stock market, and is calculated from the implied volatility of the S&P 500 options, while the VXO measures volatility in the S&P 100. It is also known by other names like “Fear Gauge” or “Fear Index.” Investors, research analysts and portfolio managers look to VIX values as a way to measure market risk, fear and stress before they take investment decisions.

Source: Charles Chapman, Bear Or Bull

On October 10th, I Know First issued a bullish

Indices Forecast

Algorithmic Trading: The New I Know First Interactive User Interface

October 16, 2018

If you are a monthly subscriber and want to receive these features simply contact our analysts HERE. They will help you with the upgrade and assist you with any remaining questions. Existing annual subscribers can add the new features free of charge, please also contact our analysts for assistance with it.

Video Tutorial

Winning Stock Forecast: Top Performers In The Long (AMD) & Short (PTLA) Position After 3 Months

October 15, 2018

Winning AMD & PTLA Forecast

Three months ago, I Know First’s predictive algorithm conducted a forecast that would predict the success of the top stock picks of both bullish and bearish positions. For the long positions, the largest growth was registered by AMD with a return of 61.74%. The package itself which consisted of 5 overall picks in the long position, had an overall average return of 19.20%, providing a premium of 14.68% over the SP500’s return of 4.52%. The best performance in the short position came from PTLA which registered a return of 40.77%. With regards to the forecasted stocks

Winning Stock Forecast

AMD Stock Forecast: AMD Keeps Up Competition With Intel and Nvidia

October 14, 2018

This article was written by Julia Masch, a Financial Analyst at I Know First.

“The continued explosion of data and the need to process, store, analyze and share it is driving industry innovation and incredible demand for compute performance in the cloud, the network and the enterprise.” -Bob Swan, Intel CFO and Interim CEO

Read The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Premium Tech Giants Stocks Forecast Tech Stocks Forecast

Stock Market Forecast: I Know First Forecasts Biggest Drop in Two Years

October 11, 2018

Stock Market Forecast

This article was written by Graham Ellinson, a Financial Analyst at I Know First currently studying Mathematics at Northumbria University Newcastle.

“There are clouds on the horizon. Growth has proven to be less balanced than we had hoped” - IMF Chief Economist Maurice Obstfeld

Summary

S&P 500 and other global indexes have taken a significant tumble in recent days
Recent blows in the U.S. China trade war result in both parties losing out
I Know First correctly forecasted this market drop across global indexes

The S&P 500-stock index fell 3.3 percent, registering its fifth consecutive daily decline. This is the longest string of down days for the S&P 500, the market’s benchmark, since November 2016. Similarly, the Dow tumbled 3.15%, or 831.83 points. This is clearly not an isolated phenomenon with Asian markets performing even worse. The Chinese benchmark equity gauge closed 5.2 percent lower and in London the FTSE 100 index was down 3.81%, a seven-month low.

Source: Shutterstock.com

Read The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Premium

Winning Stocks Forecast: CUV.AX & YOW.AX bring highest returns from Australian stock market

October 9, 2018

Winning Stocks Forecast

Clinuvel Pharmaceuticals Limited (CUV.AX)

Source: biotech-capital.com

Over the past month Clinuvel Pharmaceuticals Limited (CUV.AX) saw a rise of 49.19% this marks it as the biggest earner within Australian Stock as I Know First predicted. This surge can be attributed to the anticipated FDA approval for its drug SCENESSE® a photo-protective drug used to treat a rare condition known as targeting erythropoietic protoporphyria (EPP). SCENESSE® is already approved by the EU in 2014 and was available from 2016 across Europe. In the first half of FY18, Clinuvel had revenue of just $7 million, enough to generate

Winning Stock Forecast

Winning AMD & DDD Stock Forecast: The Biggest Of Tech Giants After Three Months

October 3, 2018

Winning AMD Stock Forecast

(By AMD via Wikimedia Commons)

In conjunction with I Know First’s 3 month algorithmic forecast, the top earner was AMD. The chipmakers’ saw increases of 106.35% at the conclusion of those months. The company that was once in big trouble has been on quite an incline. For 2018, AMD announced Q1 earnings of $1.65 billion, exceeding that with Q2 earnings of $1.76 billion. After increases in quality product, they are once again giving competitors NVDA and INTC